Stability of finished products is an issue gaining publicity and momentum. This was highlighted by the recent article, published by NutraIngredients, in which PharmaLinea’s views and research were headlined.
Our Technical Director Denis Đalapa shared surprising statistics we found during a survey at Vitafoods Europe 2019 and commented on the general awareness of industry professionals on the likelihood of ingredients’ cross-interactions within finished products. The article by journalist Shane Starling also features expert opinion by third party laboratories and regulatory authorities, who confirm our concerns.
This is another piece in the series of published content on the topic of stability by industry media (following the podcast by Vitafoods Insights and article on Natural Products INSIDER). Through such continuous education we intend to continue being ambassadors of the issue’s importance for the industry and end-users.
{Your} Iron Syrup’s efficiency was confirmed in a gold-standard clinical trial encompassing 50 children. Upon administration of our product for 12 months, ferritin levels were icreased by 56% when compared to placebo.
Klopčič went on to add: “The top-performing categories vary significantly from market to market, but the most common to take top positions are immune system, bone health, cognitive health, beauty and other health areas. The latter is a category where we often find products such as the ones addressing iron deficiency, where we are specialists. Our iron line has been in high demand because iron deficiency is typically more problematic in the region and the available solutions often come with drawbacks such as low absorption and side effects.
With markets evolving faster and faster and consumers in Southeast Asia demanding more and more from their supplement user experience, we are increasingly partnering with companies in the region by providing them with supplements in liquids, sachets, sprays, and other user-friendly product forms. Not to dismiss more traditional, yet still successful capsules and tablets.
We are currently working in Vietnam and South Korea and we are in various stages of registration processes in Indonesia, Malaysia, and the Philippines. We have already seen 100% growth in business from Southeast Asia last year and we project the growth to rise to more than 150% with the launch of more products.”
The trials were designed according to gold standards and with them, we plan to fill the gaps in the two segments by providing our clients with clearly differentiated products and clinically proven efficacy. We are also successfully developing business in the region with solutions addressing sleep and prenatal supplementation.
>Your< UTI Free Orosticks
>Your< Back Pain Capsules
>Your< Prediabetiq Capsules
WHY OUR PRODUCTS
